title: [Interleukin-2 and cancer immunotherapy].
authors.forename: V I
authors.initials: VI
authors.lastname: Ogarkov
authors.forename: A I
authors.initials: AI
authors.lastname: Dobkin
authors.forename: E V
authors.initials: EV
authors.lastname: Ryzhova
authors.forename: V B
authors.initials: VB
authors.lastname: Okulov
authors.forename: O I
authors.initials: OI
authors.lastname: Kiselev
mesh_terms: D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000628:therapy; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins
vernacular_title: Interleĭkin-2 i immunoterapiia raka.